Ovid Therapeutics Inc. Investing Cash Flow
Ovid Therapeutics Inc. (OVID) reported Investing Cash Flow of -$80.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$86.74M, a 819.65% decline year-over-year.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $5.95M, a 16.62% increase year-over-year.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$72.06M, a 438.45% decline year-over-year.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $5.05M, a 1630.48% increase year-over-year.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$49.85M, a 191.32% decline from fiscal 2024.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2024 was $54.59M.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$2.58M.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$87.88M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$86.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$80.79M 10-Q · filed 2026-08-13 | -$152.85M derived: sum of 3 quarters · filed 2026-08-13 | -$147.80M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $5.95M 10-Q · filed 2026-05-12 | -$66.11M derived: sum of 2 quarters · filed 2026-05-12 | -$61.06M derived: sum of 3 quarters · filed 2026-05-12 | -$49.01M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$72.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$67.01M derived: sum of 2 quarters · filed 2026-03-18 | -$54.96M derived: sum of 3 quarters · filed 2026-08-13 | -$49.85M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $5.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $17.11M derived: sum of 2 quarters · filed 2026-08-13 | $22.21M 10-Q · filed 2025-11-12 | $43.50M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $12.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $17.16M 10-Q · filed 2026-08-13 | $38.45M derived: sum of 3 quarters · filed 2026-08-13 | $38.74M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $5.10M 10-Q · filed 2026-05-12 | $26.39M derived: sum of 2 quarters · filed 2026-05-12 | $26.69M derived: sum of 3 quarters · filed 2026-05-12 | $39.51M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $21.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $21.58M derived: sum of 2 quarters · filed 2026-03-18 | $34.41M derived: sum of 3 quarters · filed 2026-03-18 | $54.59M 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | $292.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $13.11M derived: sum of 2 quarters · filed 2025-11-12 | $33.30M 10-Q · filed 2025-11-12 | -$15.21M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $12.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $33.01M 10-Q · filed 2025-08-13 | -$15.51M derived: sum of 3 quarters · filed 2025-08-13 | -$19.87M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $20.19M 10-Q · filed 2025-05-13 | -$28.33M derived: sum of 2 quarters · filed 2025-05-13 | -$32.69M derived: sum of 3 quarters · filed 2025-05-13 | -$12.62M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$48.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$52.88M derived: sum of 2 quarters · filed 2025-03-11 | -$32.81M derived: sum of 3 quarters · filed 2025-03-11 | -$2.58M 10-K · filed 2025-03-11 | -$2.58M 10-K · filed 2024-03-08 | |||
| 2023-09-30 | -$4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $15.71M derived: sum of 2 quarters · filed 2024-11-12 | $45.94M 10-Q · filed 2024-11-12 | $45.94M 10-Q · filed 2023-11-03 | $41.77M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $20.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $50.30M 10-Q · filed 2024-08-13 | $50.29M 10-Q · filed 2023-08-04 | $46.13M derived: sum of 3 quarters · filed 2024-08-13 | $44.17M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $30.23M 10-Q · filed 2024-05-14 | $30.23M 10-Q · filed 2023-05-05 | $26.06M derived: sum of 2 quarters · filed 2024-05-14 | $24.10M derived: sum of 3 quarters · filed 2024-05-14 | -$56.58M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$6.13M derived: sum of 2 quarters · filed 2024-03-08 | -$86.81M derived: sum of 3 quarters · filed 2024-03-08 | -$87.88M 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$82.64M derived: sum of 2 quarters · filed 2023-11-03 | -$83.71M 10-Q · filed 2023-11-03 | -$83.88M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | -$80.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$81.75M 10-Q · filed 2023-08-04 | -$81.92M derived: sum of 3 quarters · filed 2023-08-04 | -$81.98M derived: sum of 4 quarters · filed 2023-08-04 | ||||
| 2022-03-31 | -$1.08M 10-Q · filed 2023-05-05 | -$1.24M derived: sum of 2 quarters · filed 2023-05-05 | -$1.30M derived: sum of 3 quarters · filed 2023-05-05 | -$2.89M derived: sum of 4 quarters · filed 2023-05-05 | ||||
| 2021-12-31 | -$161.96K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$225.99K derived: sum of 2 quarters · filed 2023-03-13 | -$1.81M derived: sum of 3 quarters · filed 2023-03-13 | -$1.82M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | -$64.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.65M derived: sum of 2 quarters · filed 2022-11-08 | -$1.66M 10-Q · filed 2022-11-08 | -$1.75M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$1.60M 10-Q · filed 2022-08-09 | -$1.69M derived: sum of 3 quarters · filed 2022-08-09 | -$1.72M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$11.51K 10-Q · filed 2022-05-10 | -$102.00K derived: sum of 2 quarters · filed 2022-05-10 | -$140.30K derived: sum of 3 quarters · filed 2022-05-10 | $30.80M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$90.48K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$128.79K derived: sum of 2 quarters · filed 2022-03-15 | $30.81M derived: sum of 3 quarters · filed 2022-03-15 | $34.65M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | -$38.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $30.90M derived: sum of 2 quarters · filed 2021-11-10 | $34.74M 10-Q · filed 2021-11-10 | -$270.16K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $30.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $34.78M 10-Q · filed 2021-08-16 | -$231.86K derived: sum of 3 quarters · filed 2021-08-16 | -$250.44K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $3.84M 10-Q · filed 2021-05-13 | -$31.17M derived: sum of 2 quarters · filed 2021-05-13 | -$31.19M derived: sum of 3 quarters · filed 2021-05-13 | -$26.20M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$35.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$35.03M derived: sum of 2 quarters · filed 2021-03-15 | -$30.03M derived: sum of 3 quarters · filed 2021-03-15 | -$30.04M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | -$18.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $4.98M derived: sum of 2 quarters · filed 2020-11-13 | $4.97M 10-Q · filed 2020-11-13 | $21.91M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $4.99M 10-Q · filed 2020-08-10 | $21.93M derived: sum of 3 quarters · filed 2020-08-10 | $39.84M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$8.97K 10-Q · filed 2020-05-07 | $16.93M derived: sum of 2 quarters · filed 2020-05-07 | $34.84M derived: sum of 3 quarters · filed 2020-05-07 | $39.70M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $16.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $34.85M derived: sum of 2 quarters · filed 2020-03-11 | $39.71M derived: sum of 3 quarters · filed 2020-03-11 | -$5.36M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $17.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $22.77M derived: sum of 2 quarters · filed 2019-11-08 | -$22.31M 10-Q · filed 2019-11-08 | -$22.24M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $4.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$40.22M 10-Q · filed 2019-08-07 | -$40.16M derived: sum of 3 quarters · filed 2019-08-07 | -$40.18M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | -$45.07M 10-Q · filed 2019-05-07 | -$45.01M derived: sum of 2 quarters · filed 2019-05-07 | -$45.04M derived: sum of 3 quarters · filed 2019-05-07 | |||||
| 2017-12-31 | $61.71K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $36.38K derived: sum of 2 quarters · filed 2019-03-07 | -$47.39K 10-K · filed 2019-03-07 | |||||
| 2017-09-30 | -$25.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$109.09K 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$83.76K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |